MyAverix Finance
KO · Healthcare
Genesystem Co. Ltd. (363250)
Biotechnology
Genesystem Co. Ltd. (363250) is listed on KO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 363250
Genesystem Co. Ltd. (363250) — FAQ
What is 363250's P/E ratio?
The price-to-earnings (P/E) ratio for Genesystem Co. Ltd. (363250) is 18.00 (data as of 2026-03-23).
Does Genesystem Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Genesystem Co. Ltd. (363250). Check the MyAverix Finance app for the latest dividend data.
What sector is Genesystem Co. Ltd. in?
Genesystem Co. Ltd. (363250) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 363250 listed on?
363250 is listed on KO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.